FED and LCAT deficiency are rare diseases with a prevalence of <1/1,000,000 [9,10], making it difficult to prospectively enroll patients in clinical studies to evaluate visual function. The gene discussed is LCAT; the disease is hyperinsulinemic hypoglycemia, familial, 4.